Metabolic · Metabolic peptide (research)
SLU-PP-332
- Drug class
- Metabolic peptide (research)
- Status
- Compounded (503A)
- Also known as
- slu pp 332, slupp332, err agonist, exercise mimetic
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What SLU-PP-332 is studied for
- Exercise mimetic (research)
- Mitochondrial biogenesis (research)
- Endurance research (research)
Mechanism of action
SLU-PP-332 is being studied in the metabolic category. ERR agonist studied as an exercise mimetic for endurance and metabolism. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is SLU-PP-332?
SLU-PP-332 is a metabolic peptide. ERR agonist studied as an exercise mimetic for endurance and metabolism.
What is SLU-PP-332 studied for?
Published research has examined SLU-PP-332 for exercise mimetic, mitochondrial biogenesis, endurance research. Human clinical evidence varies by indication.
Is SLU-PP-332 FDA-approved?
No. SLU-PP-332 is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is SLU-PP-332 used in research?
Protocols vary by study. SLU-PP-332 is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for SLU-PP-332 is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
Build the SLU-PP-332 protocol stack
Research protocols commonly pair SLU-PP-332 with the peptides below. Add all three vials to unlock the bundle discount at checkout.
Related peptides in Metabolic
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- GLP-1s in menopauseJournal
- Menopause & weight gainJournal
- SemaglutidePeptide
- TirzepatidePeptide
- GLP-1 weight care serviceMedication
